Literature DB >> 11109159

Endometrial hyperplasia: is it time for a quantum leap to a new classification?

R J Zaino1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11109159     DOI： 10.1097/00004347-200010000-00004

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN： 0277-1691            Impact factor:   2.762


× No keyword cloud information.
  7 in total

1.  Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.

Authors:  James V Lacey; George L Mutter; Marisa R Nucci; Brigitte M Ronnett; Olga B Ioffe; Brenda B Rush; Andrew G Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz; Mark E Sherman
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 2.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

Review 3.  Precursors of endometrial and ovarian carcinoma.

Authors:  Robert J Kurman; Thomas G McConnell
Journal:  Virchows Arch       Date:  2009-10-27       Impact factor: 4.064

4.  Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.

Authors:  James V Lacey; Mark E Sherman; Brenda B Rush; Brigitte M Ronnett; Olga B Ioffe; Máire A Duggan; Andrew G Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

Review 5.  The endometrial hyperplasias revisited.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki
Journal:  Virchows Arch       Date:  2008-08-23       Impact factor: 4.064

Review 6.  New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.

Authors:  Katarzyna Sobczuk; Anna Sobczuk
Journal:  Prz Menopauzalny       Date:  2017-10-12

7.  Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.

Authors:  J V Lacey; O B Ioffe; B M Ronnett; B B Rush; D A Richesson; N Chatterjee; B Langholz; A G Glass; M E Sherman
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.